This miRNA is predicted to target the Cyclin Dependent Kinase Inhibitor 2C (CDKN2C) tumor suppressor gene, encoding the p18/INK4c, an inhibitor of the cyclin kinases CDK4 and CDK6, which negatively controls the cell cycle G1 progression, and whose somatic inactivating mutations have been found in sporadic PAs [14]. Here, CDKN2C is linked to gonorrhea.